Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study.
- DOI
- 10.1186/s12916-026-04755-6
- Published
- 2026 Mar 3
- Container
- BMC medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12916-026-04755-6,
title = {Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study.},
author = {Yu J and Song F and Zhang M and Zhao M and Sang W and Jiang S and Wang L and Wang X and Tu S and Li Y and Huang H and Hu Y and Wei G},
year = {2026},
journal = {BMC medicine},
doi = {10.1186/s12916-026-04755-6},
url = {https://doi.org/10.1186/s12916-026-04755-6}
}RIS
TY - JOUR TI - Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study. AU - Yu J AU - Song F AU - Zhang M AU - Zhao M AU - Sang W AU - Jiang S AU - Wang L AU - Wang X AU - Tu S AU - Li Y AU - Huang H AU - Hu Y AU - Wei G PY - 2026 JO - BMC medicine DO - 10.1186/s12916-026-04755-6 UR - https://doi.org/10.1186/s12916-026-04755-6 ER -
APA
J, Y., F, S., M, Z., M, Z., W, S., S, J., L, W., X, W., S, T., Y, L., H, H., Y, H., & G, W. (2026). Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study.. BMC medicine. https://doi.org/10.1186/s12916-026-04755-6
Source records
- pubmed · retrieved 2026-09-26T15:44:02.553Z